Filter by Day
Filter by Category
Main Program
Nursing Symposium
Oral Presentations
Industry
MSIF
Full Agenda

PARADIGMS, Al Baraha 1

17:30
|
18:00

Registration
18:00
|
18:05

Welcome and Introduction
08:30
|
09:15
Lectures
Chairs: B. Yamout (AE) & C. Oreja-Guevara (ES)
ON DEMAND
  1. 18:05
    Pregnancy and Lactation in Patients with MS
    B. Yamout (AE)
  2. 18:25
    Live Q&A
  3. 18:30
    Human response to COVID-vaccination in MS
    C. Oreja-Guevara (ES)
  4. 18:50
    Live Q&A
  5. 18:55
    How to Mitigate Risks in MS
    M. Pugliatti (IT)
  6. 19:15
    Hot Topics Panel Discussion
19:30
|
20:00

Coffee and Networking

MS MEDICAL GRAND ROUNDS
THURSDAY, DECEMBER 9


LIVE HALL A
LIVE HALL B
LIVE HALL C
19:30
|
20:00

Registration
20:00
|
20:05

Welcome and Introduction
20:05
|
21:00
Case Discussions
Panelists: C. Oreja-Guevara (ES), G. Giovannoni (UK) & N. De Stefano (IT)
ON DEMAND
21:00
|
22:30

Dinner

FRIDAY, DECEMBER 10

08:00
|
09:00

Registration & Morning Coffee
09:00
|
10:15
Session I: Progressive MS
Chairs: J. Inshasi (AE), M. Zakaria (EG)
ON DEMAND
  1. 09:00
    Defining Secondary Progressive MS: When does it start?
    M. Zakaria (EG)
  2. 09:20
    Update on the Treatment of Progressive MS
    G. Giovannoni (UK)
  3. 09:40
    How to Monitor Treatment Efficacy in Progressive MS?
    H. P. Hartung (DE)
  4. 10:00
    Panel Discussion
10:15
|
10:30

Coffee Break
10:30
|
11:00
Satellite Symposium I hosted by Novartis
Chair: B. Yamout (AE)
ON DEMAND
  1. 10:30
    The Next Generation in B-Cell-Targeted Therapies
    E. Alvarez (US)
11:00
|
12:00
Session II: COVID-19 and MS
Chairs: S. Bohlega (SA), M. Dahdaleh (JO)
ON DEMAND
  1. 11:00
    Disease Modifying Therapies and COVID-19
    M.P. Sormani (IT)
  2. 11:25
    COVID-19 Vaccination and MS: MENACTRIMS Practice Guidelines
    B. Yamout (AE)
  3. 11:50
    Panel Discussion
12:00
|
13:00

Prayer Break and Lunch
13:00
|
14:15
Session III: NMO and MOGAD
Chairs: A. Jacob (AE), M. Al-Jummah (SA)
ON DEMAND
  1. 13:00
    How to Differentiate MS, NMO and MOGAD
    R. Alroughani (KW)
  2. 13:20
    Update on the Treatment of NMO
    K. Fujihara (JP)
  3. 13:40
    Update on the Treatment of MOGAD
    T. Berger (AT)
  4. 14:00
    Panel Discussion
14:15
|
14:30
Welcome and Introduction by B. Yamout (AE),
President of MENACTRIMS
14:30
|
15:00
Satellite Symposium II hosted by Merck
Chair: J. Inshasi (AE)
ON DEMAND
  1. Getting Closer to Life Without MS
  2. Treatment with IRT vs. Continuous Immunosuppression
    G. Giovannoni (UK)
  3. Efficacy of MAVENCLAD® Beyond Dosing Schedule
    B. Yamout (AE)
15:00
|
16:15
Session IV: The Clinical Spectrum of MS
Chairs: M. Shakra (AE), R. Gouider (TN)
ON DEMAND
  1. 15:00
    The MS Prodrome: When does MS start?
    M. Tintore (ES)
  2. 15:20
    MS in Elderlies: Diagnosis and Treatment
    R. Gouider (TN)
  3. 15:40
    MS in Children and Adolescents
    S. Al Jarallah (SA)
  4. 16;00
    Panel Discussion
16:15
|
16:30

Coffee Break
16:30
|
17:00
Satellite Symposium III hosted by Biogen
Chair: K.Curnow (CH)
ON DEMAND
  1. Adapting to Today’s World Through Individualised Patient Care
  2. Natalizumab: Key Advances Impacting Clinical Decisions
    S. Meuth (DE)
17:00
|
18:00
Session V: Oral Presentations
Chairs: M. Zakaria (EG), R. Alroughani (KW)
ON DEMAND
  1. 17:00
    Humoral Immune Response to SARS-CoV-2 Vaccination in MS Patients
    C. Oreja-Guevara (ES)
  2. 17:10
    COVID19 in Multiple Sclerosis Patients in Dubai: Observational Study
    M. Thakre (AE)
  3. 17:20
    Chitinase-3 Like-Protein-1 in CSF: A Novel Biomarker for Progression in Multiple Sclerosis Patients
    A. Dahshan (EG)
  4. 17:30
    Radiologically Isolated Syndrome Conversion to Multiple Sclerosis
    F. Sabeti (IR)
  5. 17:40
    Serum Neurofilament Light Chain as a Biomarker in Multiple Sclerosis
    H. K.Hassoun (IQ)
  6. 17:50
    Long-Term Efficacy for Patients Receiving Cladribine Tablets in CLARITY/CLARITY Extension: Primary Results from 9–15 Years of Follow-Up in the CLASSIC-MS Study
    G. Giovannoni (UK)
19:30
|
22:30

Congress Dinner

SATURDAY, DECEMBER 11

09:00
|
10:15
Session VI: Hot Topics in MS
Chairs: C. Oreja-Guevara (ES), A. Shatila (AE)
ON DEMAND
  1. 09:00
    The Gut Microbiome in MS
    N. Grigoriadis (GR)
  2. 09:20
    Vitamin D and MS
    C. Oreja-Guevara (ES)
  3. 09:40
    Comorbidities in MS: Do they play a role?
    X. Montalban (ES)
  4. 10:00
    Panel Discussion
10:15
|
10:30

Coffee Break
10:30
|
11:00
Satellite Symposium IV hosted by Biologix
Chair: M. A. Sahraian (IR)
ON DEMAND
  1. Individualizing Treatment Strategies in MS: Long-Term Data and Experience
    B. Kallmann (DE)
11:00
|
12:15
Session VII: European Charcot Foundation (ECF) Symposium: Neural Repair and Remyelination in MS
Chairs: C. Lubetzki (FR), B. Yamout (AE)
ON DEMAND
  1. 11:00
    Cellular Therapies to Enhance Remyelination
    G. Martino (IT)
  2. 11:15
    Functional Biomarkers to Assess and Monitor Demyelination / Remyelination Processes
    L. Leocani (IT)
  3. 11:30
    Imaging of Demyelination / Remyelination
    B. Stankoff (FR)
  4. 11:45
    Remyelinating Treatments: Present and Future
    C. Lubetzki (FR)
  5. 12:00
    Panel Discussion
12:15
|
12:45
Satellite Symposium V hosted by Roche
Chair: R. Alroughani (KW)
ON DEMAND
  1. 11:00
    Shifting Focus in MS: From Evolution to Revolution
    R. A. Bermel (US)
14:00
|
15:15
Session VIII: Advances in MRI
Chairs: N. De Stefano (IT), M. Sahraian (IR)
ON DEMAND
  1. 14:00
    2021 MAGNIMS Guidelines for the Use of MRI in MS
    N. De Stefano (IT)
  2. 14:20
    Differential Diagnosis of MS Lesions on MRI
    M. Sahraian (IR)
  3. 14:40
    Recent Advances in MS Neuroimaging
    B. Stankoff (FR)
  4. 15:00
    Panel Discussion
15:15
|
15:45
Satellite Symposium VI hosted by Hikma
Chair: R. Gouider (TN)
ON DEMAND
  1. DMF: Real Life Experience
    H. Aref (EG)
15:45
|
16:00

Coffee Break
16:00
|
17:00
Session IX: Biomarkers in MS
Chairs: C. Oreja-Guevara (ES), R. Gouider (TN)
ON DEMAND
  1. 16:00
    Neurofilaments and Other Upcoming Biomarkers
    S. Khoury (LB))
  2. 16:25
    OCT and Evoked Potentials
    L. Leocani (IT)
  3. 16:50
    Panel Discussion
17:00
|
17:30

Closing Ceremony and Awards Presentation

MSIF SYMPOSIUM
SATURDAY, DECEMBER 11, Virtual

14:00
|
15:00
Session I
ON DEMAND
  1. Key Research Updates from MENACTRIMS Congress
    R. Alroughani (KW)
15:00
|
17:15
Session II: MSIF’s Global Access Work - Progress Made
ON DEMAND
  1. 15:00
    MSIF Global Access Work Overview
    J. Laurson-Doube (HK)
  2. 15:30
    Short Break
  3. 15:45
    MSIF Off-Label Treatments Panel
    S. Viswanathan (MY)
  4. 16:15
    Access to Treatment and MOLT into Action in Morocco
    N. Abkari (MA)
  5. 16:45
    Access to Treatment and MOLT into Action in Malaysia
    S. Viswanathan (MY)

NURSING SYMPOSIUM
SATURDAY, DECEMBER 11, Al Amwaj

09:00
|
10:30
Nursing Session I: Approaches to MS Care in Special Populations
Chair: J. Massouh (AE)
ON DEMAND
  1. 09:00
    Aging in Multiple Sclerosis
    M. Namey (US)
  2. 09:30
    Advanced Multiple Sclerosis
    J. Massouh (AE)
  3. 10:00
    Treatments for Pediatric Multiple Sclerosis
    M. Zeineddine (AE)
10:30
|
10:45

Coffee Break
10:45
|
12:15
Nursing Session II: Patient-Centered Care
Chair: J. Massouh (AE)
ON DEMAND
  1. 10:45
    Maintaining a Healthy Lifestyle in MS
    M. Namey (US)
  2. 11:30
    Patient Partnerships in Multiple Sclerosis Care
    T. Bharadia (UK)
12:15
|
13:30

Lunch Break
13:30
|
14:00
Nursing Satellite Symposium I hosted by Novartis
Chair: J. Massouh (AE)
ON DEMAND
  1. MS Nursing: Expanding the Boundaries of Care
    M. Namey (US) & J. Massouh (AE)
14:00
|
14:30
Nursing Satellite Symposium II hosted by Merck
ON DEMAND
  1. Factors to Consider when Planning MS Treatment: A Conversation Guide between MS Nurse and the Patient
    J. Massouh (AE)
14:30
|
15:00

Nursing Satellite Symposium III hosted by Biologix
ON DEMAND
  1. The Art and Science of Multiple Sclerosis Medications Counseling
    M. Zeineddine (AE)
15:00
|
15:30

Nursing Satellite Symposium IV hosted by Roche
ON DEMAND
  1. OCREVUS: Similar Efficacy, Simpler Infusion
    R. Alarieh (SA)
15:30
|
16:00
Networking Hour
J. Halper (US), M. Namey (US), J. Massouh (AE)